| Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume DH Vu, RA Koster, JWC Alffenaar, J Brouwers, DRA Uges Journal of Chromatography B 879 (15-16), 1063-1070, 2011 | 184 | 2011 |
| Bedaquiline resistance: its emergence, mechanism, and prevention TVA Nguyen, RM Anthony, AL Bañuls, TVA Nguyen, DH Vu, ... Clinical Infectious Diseases 66 (10), 1625-1630, 2018 | 169 | 2018 |
| Dried blood spots: a new tool for tuberculosis treatment optimization D H Vu, J WC Alffenaar, P M Edelbroek, J RBJ Brouwers, D RA Uges Current pharmaceutical design 17 (27), 2931-2939, 2011 | 107 | 2011 |
| Simultaneous determination of rifampicin, clarithromycin and their metabolites in dried blood spots using LC–MS/MS DH Vu, RA Koster, MS Bolhuis, B Greijdanus, RV Altena, DH Nguyen, ... Talanta 121, 9-17, 2014 | 103 | 2014 |
| Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Linezolid in Patients with Multidrug-Resistant Tuberculosis DH Vu, MS Bolhuis, RA Koster, B Greijdanus, WCM de Lange, ... Antimicrobial agents and chemotherapy 56 (11), 5758-5763, 2012 | 99 | 2012 |
| Clinical standards for the dosing and management of TB drugs JWC Alffenaar, SL Stocker, LD Forsman, A Garcia-Prats, SK Heysell, ... The International Journal of Tuberculosis and Lung Disease 26 (6), 483-499, 2022 | 51 | 2022 |
| Troubleshooting carry-over of LC–MS/MS method for rifampicin, clarithromycin and metabolites in human plasma DH Vu, RA Koster, AMA Wessels, B Greijdanus, JWC Alffenaar, ... Journal of Chromatography B 917, 1-4, 2013 | 50 | 2013 |
| Delamanid resistance: update and clinical management TVA Nguyen, RM Anthony, TTH Cao, AL Bañuls, VAT Nguyen, DH Vu, ... Clinical Infectious Diseases 71 (12), 3252-3259, 2020 | 40 | 2020 |
| Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam DH Vu, N van Rein, FGJ Cobelens, TTH Nguyen, VH Le, J Brouwers The International Journal of Tuberculosis and Lung Disease 16 (12), 1625-1629, 2012 | 37 | 2012 |
| Bedaquiline as part of combination therapy in adults with pulmonary multi-drug resistant tuberculosis TVA Nguyen, TBT Cao, OW Akkerman, S Tiberi, DH Vu, JWC Alffenaar Expert Review of Clinical Pharmacology 9 (8), 1025-1037, 2016 | 34 | 2016 |
| Drug‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis KD Nguyen, TN Tran, MLT Nguyen, HA Nguyen, HA Nguyen Jr, DH Vu, ... Journal of clinical pharmacy and therapeutics 44 (1), 69-77, 2019 | 28 | 2019 |
| A review of the literature on the economics of vaccination against TB HAT Tu, HD Vu, MH Rozenbaum, HJ Woerdenbag, MJ Postma Expert Review of Vaccines 11 (3), 303-317, 2012 | 27 | 2012 |
| Determination of optimal loading and maintenance doses for continuous infusion of vancomycin in critically ill patients: Population pharmacokinetic modelling and simulations … DH Vu, DA Nguyen, IK Delattre, TT Ho, HG Do, HN Pham, XC Dao, ... International journal of antimicrobial agents 54 (6), 702-708, 2019 | 25 | 2019 |
| Exploring associations of 6-thioguanine nucleotide levels and other predictive factors with therapeutic response to azathioprine in pediatric patients with IBD using multilevel … TVA Nguyen, DH Vu, TMH Nguyen, A Lachaux, R Boulieu Inflammatory bowel diseases 19 (11), 2404-2410, 2013 | 24 | 2013 |
| Relationship Between Azathioprine Dosage and Thiopurine Metabolites in Pediatric IBD Patients: Identification of Covariables Using Multilevel Analysis RB Thi-Van-Anh Nguyen, Dinh H Vu, Thi-Mai-Hoang Nguyen, Alain Lachaux Therapeutic Drug Monitoring 35 (2), 251-257, 2013 | 20 | 2013 |
| Drug-induced anaphylaxis in a Vietnamese Pharmacovigilance Database: trends and specific signals from a disproportionality analysis KD Nguyen, HA Nguyen, DH Vu, TTL Le, HA Nguyen, BV Dang, ... Drug safety 42, 671-682, 2019 | 19 | 2019 |
| Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam NB Ngoc, H Vu Dinh, NT Thuy, DV Quang, CTT Huyen, NM Hoa, NH Anh, ... PloS one 16 (9), e0255357, 2021 | 14 | 2021 |
| Antibiotic therapy for inpatients with community‐acquired pneumonia in a developing country HT Trinh, PH Hoang, M Cardona‐Morrell, HT Nguyen, DH Vu, PTX Dong, ... Pharmacoepidemiology and drug safety 24 (2), 129-136, 2015 | 13 | 2015 |
| Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review PS Rao, N Modi, NTT Nguyen, DH Vu, YL Xie, M Gandhi, R Gerona, ... Clinical Pharmacokinetics 62 (3), 375-398, 2023 | 9 | 2023 |
| Integration of drug safety monitoring in tuberculosis treatment programmes: country experiences E Tiemersma, S van den Hof, G Dravniece, F Wares, Y Molla, Y Permata, ... European Respiratory Review 28 (153), 2019 | 9 | 2019 |
